On-Demand Webinars

  1. Spray Dried Biologics For Pulmonary Dosage Forms 5/8/2026

    View how spray drying enables stable, precisely engineered pulmonary powders for biologics, supporting efficient lung delivery, scalability, and preservation of molecular structure and activity.

  2. Early Developability Assessment For Antibody Based Therapeutics 5/7/2026

    Learn how an integrated developability and immunosafety toolbox can help de-risk multi-specific antibody development, improve candidate selection, and accelerate complex biologics toward the clinic.

  3. Enhancing Gene Editing Outcomes And Safety for Clinical Translation With Next Generation Vectors 5/6/2026

    Learn how streamlined vector backbones can improve efficiency, consistency, and expression durability when reliability matters most.

  4. Spray Dried Biologics For Nasal Dosage Forms 5/5/2026

    A fireside chat explores spray drying for nasal biologics, covering formulation science, particle design, delivery advantages, and testing strategies to move from concept to clinic.

  5. Spray Dried Biologics For OSD Dosage Forms 5/5/2026

    A fireside chat explores spray drying basics, oral biologic dosage forms, formulation hurdles, and testing strategies to ensure drug product quality, safety, and performance.

  6. Spray Dried Biologics For Injectable Dosage Forms 5/1/2026

    Experts highlight spray drying as a gentle, scalable way to stabilize biologics, supporting high‑concentration injectables with controlled particles, sterility, and flexible delivery.

  7. Engineering Precision In Genetic Medicines 4/30/2026

    Precision genome editing strategies that balance specificity and potency through advanced engineering workflows, AI‑driven optimization, and tailored editor design for clinical genetic medicines.

  8. Using Full DEL Data To Improve Early Compound Decisions 4/29/2026

    High-throughput screens hold insights beyond individual hits. Examine a broader view of screening data that reveals structure–function patterns to guide smarter compound prioritization.

  9. From DNA To IND In As Little As 6 Months 4/27/2026

    Discover how an integrated, platform-driven CMC approach can accelerate your antibody program from DNA to IND in as little as six months while reducing risk and maintaining quality and regulatory alignment.

  10. Biologics Tech Transfer & Validation at Scale: A Better Path to GMP 4/24/2026

    Explore where tech transfer and validation commonly falter, and how disciplined execution helps teams maintain control through PPQ and beyond.